Does VALSARTAN Cause Neoplasm malignant? 280 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 280 reports of Neoplasm malignant have been filed in association with VALSARTAN (valsartan). This represents 1.3% of all adverse event reports for VALSARTAN.
280
Reports of Neoplasm malignant with VALSARTAN
1.3%
of all VALSARTAN reports
24
Deaths
67
Hospitalizations
How Dangerous Is Neoplasm malignant From VALSARTAN?
Of the 280 reports, 24 (8.6%) resulted in death, 67 (23.9%) required hospitalization, and 26 (9.3%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 280 reports have been filed with the FAERS database.
What Other Side Effects Does VALSARTAN Cause?
Drug ineffective (1,845)
Blood pressure increased (1,682)
Dizziness (1,527)
Headache (1,361)
Hypertension (1,341)
Acute kidney injury (1,301)
Dyspnoea (1,239)
Fatigue (1,156)
Malaise (1,139)
Hypotension (1,032)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which VALSARTAN Alternatives Have Lower Neoplasm malignant Risk?
VALSARTAN vs VALTREX
VALSARTAN vs VAMOROLONE
VALSARTAN vs VANCOMYCIN
VALSARTAN vs VANDETANIB
VALSARTAN vs VARDENAFIL